Current prescription status of antihypertensive drugs in Japanese patients with hypertension: Analysis by type of comorbidities

Clinical and Experimental Hypertension : CHE
Takayuki IshidaTakuya Tsuchihashi

Abstract

In 2014, the Japanese Society of Hypertension (JSH) issued revised guidelines for hypertension management. To assess adherence to the guidelines, this retrospective study evaluated the real-world status of antihypertensive drug prescribing for Japanese patients with hypertension, classified by comorbidity: diabetes mellitus, dyslipidemia, gout/hyperuricemia and renal diseases. Data on 59,867 hypertensive patients who received their first prescription for antihypertensive therapy between April 2014 and March 2015, were obtained from a medical insurance claims database for hospitals participating in the Diagnosis Procedure Combination/Per-Diem payment system. The most common drugs prescribed for each comorbidity subgroup were calcium channel blockers (CCBs) and angiotensin II receptor blockers (ARBs), with prescription rates of around 60-70%. Contrary to JSH recommendations, diuretics and angiotensin-converting enzyme inhibitors were prescribed less often than β-blockers. Whereas diabetes mellitus is a compelling indication for use of renin-angiotensin system inhibitors, CCBs were commonly prescribed in this subgroup. The treatment pattern for patients with comorbid dyslipidemia closely resembled that for the overall patient popu...Continue Reading

References

Dec 29, 2000·Hypertension Research : Official Journal of the Japanese Society of Hypertension·S KatayamaR Kikkawa
Jun 14, 2005·Journal of Human Hypertension·K ChenR Dubois
Mar 17, 2010·The New England Journal of Medicine·William C CushmanFaramarz Ismail-Beigi
Jun 7, 2012·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Hege Salvesen BlixAsmund Reikvam
Feb 8, 2013·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Takahide KohroRyozo Nagai
Jun 14, 2013·Annales de cardiologie et d'angéiologie·X GirerdJ-J Mourad
Aug 2, 2013·Circulation Journal : Official Journal of the Japanese Circulation Society·Katsuyuki MiuraTakayoshi Ohkubo
Nov 26, 2014·American Journal of Hypertension·Sudhir UnniDiana Brixner
Nov 10, 2015·The New England Journal of Medicine·UNKNOWN SPRINT Research GroupWalter T Ambrosius
Mar 31, 2016·Clinical and Experimental Hypertension : CHE·Yasuo KansuiKiyoshi Matsumura
May 14, 2016·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Masaki MogiSatoshi Umemura
Jul 29, 2016·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Shinzo HiroiMitsuru Ohishi
Sep 2, 2016·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Ai IbarakiTakuya Tsuchihashi

❮ Previous
Next ❯

Citations

Jan 31, 2020·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Takuo YoshidaNaoyuki Hasebe
Apr 22, 2020·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Shiori NishimuraHiroaki Miyata
Jan 26, 2021·The Journal of Clinical Hypertension·Mi-Hyang JungKi-Chul Sung
May 9, 2021·Journal of Human Hypertension·Kazuomi KarioHiromi Rakugi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.